Abstract |
Altered l-arginine metabolism has been described in patients with COVID-19 and has been associated with immune and vascular dysfunction. In the present investigation, we determined the serum concentrations of l-arginine, citrulline, ornithine, monomethyl- l-arginine (MMA), and symmetric and asymmetric dimethylarginine (SDMA, ADMA) in adults with long COVID at baseline and after 28-days of l-arginine plus vitamin C or placebo supplementation enrolled in a randomized clinical trial, compared with a group of adults without previous history of SARS-CoV-2-infection. l-arginine-derived markers of nitric oxide (NO) bioavailability (i.e., l-arginine/ADMA, l-arginine/citrulline+ornithine, and l-arginine/ ornithine) were also assayed. Partial least squares discriminant analysis (PLS-DA) models were built to characterize systemic l-arginine metabolism and assess the effects of the supplementation. PLS-DA allowed discrimination of participants with long COVID from healthy controls with 80.2 ± 3.0% accuracy. Lower markers of NO bioavailability were found in participants with long COVID. After 28 days of l-arginine plus vitamin C supplementation, serum l-arginine concentrations and l-arginine/ADMA increased significantly compared with placebo. This supplement may therefore be proposed as a remedy to increase NO bioavailability in people with long COVID.
|
Authors | Riccardo Calvani, Jacopo Gervasoni, Anna Picca, Francesca Ciciarello, Vincenzo Galluzzo, Hélio José Coelho-Júnior, Clara Di Mario, Elisa Gremese, Sara Lomuscio, Anna Maria Paglionico, Lavinia Santucci, Barbara Tolusso, Andrea Urbani, Federico Marini, Emanuele Marzetti, Francesco Landi, Matteo Tosato, Gemelli against COVID-19 Post-Acute Care Team |
Journal | International journal of molecular sciences
(Int J Mol Sci)
Vol. 24
Issue 6
(Mar 07 2023)
ISSN: 1422-0067 [Electronic] Switzerland |
PMID | 36982151
(Publication Type: Randomized Controlled Trial, Journal Article)
|
Chemical References |
- Ascorbic Acid
- Citrulline
- Arginine
- Nitric Oxide
- Ornithine
|
Topics |
- Humans
- Adult
- Post-Acute COVID-19 Syndrome
- Ascorbic Acid
(therapeutic use)
- Citrulline
(metabolism)
- COVID-19
- SARS-CoV-2
(metabolism)
- Arginine
(metabolism)
- Nitric Oxide
(metabolism)
- Ornithine
- Dietary Supplements
|